Projects per year
Search results
-
Active
Predicting Quality of Response to Specific Treatments (PQRST)
FRED HUTCHINSON CANCER CENTER, NIH NATIONAL CANCER INSTITUTE (NCI)
4/1/23 → 3/31/25
Project: Research project
-
Predicting Quality of Response to Specific Treatments (PQRST)
FRED HUTCHINSON CANCER CENTER, NIH NATIONAL CANCER INSTITUTE (NCI)
4/1/23 → 3/31/25
Project: Research project
-
MT2019-37: A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase III Trial of Alpha 1 -Antitrypsin (AAT) Combined with Corticosteroids vsCorticosteroids Alone for the Treatment of High Risk Acute Graft-versus-HostDisea
NATIONAL MARROW DONOR PROGRAM, CSL BEHRING GMBH
10/1/19 → 10/31/24
Project: Research project
-
Finished
Predicting Quality of Response to Specific Treatments (PQRST)
FRED HUTCHINSON CANCER CENTER, NATIONAL INSTITUTES OF HEALTH (NIH)
4/1/22 → 3/31/23
Project: Research project
-
Predicting Quality of Response to Specific Treatments (PQRST)
FRED HUTCHINSON CANCER CENTER, NATIONAL INSTITUTES OF HEALTH (NIH)
4/1/22 → 3/31/23
Project: Research project
-
Predicting Quality of Response to Specific Treatments (PQRST)
El Jurdi, N. & Arora, M.
FRED HUTCHINSON CANCER CENTER, NIH NATIONAL CANCER INSTITUTE (NCI)
4/16/20 → 3/31/22
Project: Research project
-
Predicting Quality of Response to Specific Treatments (PQRST)
El Jurdi, N. & Arora, M.
FRED HUTCHINSON CANCER CENTER, NIH NATIONAL CANCER INSTITUTE (NCI)
4/16/20 → 3/31/22
Project: Research project
-
Immune Tolerance Network / BEAT-MS
Carpenter, A., Brunstein, C. G., El Jurdi, N., Schmalstieg, W. & Nelson, F.
BENAROYA RESEARCH INST AT VIRGINIA MASON, NIH Nat'l Inst of Allergy & Infect Dis
2/1/20 → 1/31/24
Project: Research project
-
-
A Randomized, Multicenter, Phase III Trial of Tacrolimus/Methotrexate versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation
NATIONAL MARROW DONOR PROGRAM, NATIONAL INSTITUTES OF HEALTH (NIH)
3/6/19 → 3/30/24
Project: Research project
-
A Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
11/27/18 → 11/30/23
Project: Research project